Wuhan Jingkangen Biomedical Technology Co., Ltd
Firmenname:
Wuhan Jingkangen Biomedical Technology Co., Ltd
Telefon:
00-13720134139 +86 -0-15871494362
E-Mail:
orders@jknbiochem.com
Nationalität:
China
URL:
www.jknbiochem.com
Produkte insgesamt:
4959
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
Produktkatalog
1H-1,4-Benzodiazepine-2-methanamine, 7-chloro-2,3-dihydro-5-phenyl-
138729-68-7
C16H16ClN3
NA
58468-07-4
MK-1775
955365-80-7
C27H32N8O2
8H-[1,4]Diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one, 3-[[2-chloro-5-(ethoxymethyl)-4-pyrimidinyl]oxy]-9,10,11,12-tetrahydro-10-methyl-, (10R)-
1887069-10-4
C22H20ClN5O3S
IAG933
2714434-21-4
4-[4-(4-amino-1,2,5-oxadiazol-3-yl)-2-oxido-1,2,5-oxadiazol-3-yl]-1,2,5-oxadiazol-3-amine
296244-55-8
C6H4N8O4
Indusatumab Vedotin
1514889-12-3
Sevirumab
138660-96-5
Meplazumab
2413715-21-4
Andecaliximab
1518996-49-0
Obiltoxaximab
1351337-07-9
Indusatumab
1497400-26-6
Lilotomab
1453362-55-4
Isatuximab
1461640-62-9
Research Grade Nemolizumab
1476039-58-3
Brolucizumab
1531589-13-5
Tesidolumab
1531594-08-7
Bermekimab
1401965-15-8
Istiratumab
1509928-04-4
Pepinemab
2097151-87-4
Elgemtumab
1512559-37-3
Difluprednate Impurity 16
2326-26-3
C23H26F2O5
Fluocinolone acetonide
Fluocinolonacetonid
67-73-2
C24H30F2O6
Fluocinonide
Fluocinonid
356-12-7
C26H32F2O7
Methylprednisolone acetate
Methylprednisolon-21-acetat
53-36-1
C24H32O6
Methylprednisolone Hemisuccinate
11β,17,21-Trihydroxy-6α-methylpregna-1,4-dien-3,20-dion-21-(hydrogensuccinat)
2921-57-5
C26H34O8
Triamcinolone
Triamcinolon
124-94-7
C21H27FO6
Clascoterone
19608-29-8
C24H34O5
Prednisone Phosphate Disodium Salt/17-Hydroxy-21-(phosphonooxy)pregna-1,4-diene-3,11,20-trione disodium salt
Pregna-1,4-dien-3,11,20-trion, 17-Hydroxy-21-(phosphonooxy)-, Dinatriumsalz
33903-70-7
C21H25Na2O8P
Prednisolone phosphate sodium
Prednisolon-21-(dinatriumphosphat)
125-02-0
C21H27Na2O8P
Anecortave Acetate
17-α,21-Dihydroxypregna-4,9(11)-dien-3,20-dion-21-acetat
7753-60-8
C23H30O5
Prednisolone Hemisuccinate
Prednisolon-21-(hydrogensuccinat)
2920-86-7
C25H32O8
loteprednol etabonate
82034-46-6
C24H31ClO7
Prednisolone Valeroacetate
11β,17,21-Trihydroxypregna-1,4-dien-3,20-dion-21-acetat-17-valerat
72064-79-0
C28H38O7
Fludrocortisone acetate
Fludrocortison-21-acetat
514-36-3
C23H31FO6
11α-Hydroxyprogesterone
11-α-Hydroxypregn-4-en-3,20-dion
80-75-1
C21H30O3
Difluprednate
Difluprednat
23674-86-4
C27H34F2O7
BEMPEDOIC ACID
738606-46-7
C19H36O5
prednisolon
Prednisolon
50-24-8
C21H28O5
Deflazacort
Deflazacort
14484-47-0
C25H31NO6
Cortisone
Cortison
53-06-5
C21H28O5
Gepotidacin
1075236-89-3
C24H28N6O3
Budesonide
16α(R),17-[Butylidenbis(oxy)]-11β,21-dihydroxypregna-1,4-dien-3,20-dion
51372-29-3
C25H34O6
Triamcinolone Acetonide EP Impurity E
9-Fluor-11β,21-dihydroxy-16α,17-(isopropylidendioxy)pregn-4-en-3,20-dion
1524-86-3
C24H33FO6
triamcinolone acetonide
9-α-Fluor-11-β,21-dihydroxy-16-α,17-α-isopropylidendioxypregna-1,4-dien-3,20-dion
76-25-5
C24H31FO6
Hydrocortisone-17-butyrate
11β,17,21-Trihydroxypregn-4-en-3,20-dion-17-butyrat
13609-67-1
C25H36O6
cortisol sodium phosphate
Pregn-4-en-3,20-dion, 11,17-Dihydroxy-21-(phosphonooxy)-, Dinatriumsalz, (11β)-
6000-74-4
C21H29O8P.2Na
Hydrocortisone Sodium Succinate
Hydrocortison-21-(natriumsuccinat)
125-04-2
C25H33O8.Na
Hydrocortisone 17-valerate
11β,17,21-Trihydroxypregn-4-en-3,20-dion-17-valerat
57524-89-7
C26H38O6
Fmoc-N'-methyltrityl-L-lysine
167393-62-6
C41H40N2O4
ZN-c3
2376146-48-2
C29H34N8O2
Enoblituzumab
1353485-38-7
Refanezumab
1233953-61-1
Crotedumab
1452387-69-7
Mirvetuximab
1453084-36-0
Blontuvetmab
1608112-78-2
Tamtuvetmab
1608122-71-9
Navicixizumab
1638338-43-8
Rivabazumab
1627519-84-9
Prezalumab
1523164-68-2
Laprituximab
1622327-38-1
Naratuximab
1622327-39-2
Rozanolixizumab
1584645-37-3
Suptavumab
1629615-23-1
Birtamimab
1608108-91-3
Erenumab
1582205-90-0
Domagrozumab
1629605-31-7
Galcanezumab
1578199-75-3
Research Grade Setrusumab
1847394-95-9
Duvortuxizumab
1831098-91-9
Research Grade Apamistamab
2097132-02-8
Vadastuximab
1436390-63-4
Vonlerolizumab
1638935-72-4
Lanadelumab
1426055-14-2
Timolumab
1073538-99-4
Carotuximab
1268714-50-6
Lupartumab
1640971-88-5
Tezepelumab
1572943-04-4
Research Grade Ifabotuzumab
1234137-51-9
Plozalizumab
1610761-46-0
Rovalpituzumab
1613313-01-1
Tilavonemab
2096513-89-0
Landogrozumab
1391726-30-9
Tisotumab
1418628-81-5
Afasevikumab
1589503-30-9
Rinucumab
1569263-06-4
Research Grade Gontivimab
1257358-38-5
Olendalizumab
1337966-73-0
Satralizumab
1535963-91-7
Cabiralizumab
1613144-80-1
Xentuzumab
1417158-65-6
Bleselumab
1453067-91-8
Monalizumab
1228763-95-8
Ascrinvacumab
1463459-96-2
Inebilizumab
1299440-37-1
Navivumab
1443004-16-7
Research Grade Cergutuzumab
1509916-03-3
Trevogrumab
1429201-24-0
Opicinumab
1422268-07-2
Clivatuzumab Tetraxetan
1462876-11-4
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
Copyright 2019 © ChemicalBook. All rights reserved